Adagio Therapeutics, Inc. ADGI

ADGI Quotes by TradingView
Institutional shares held 70.5 Million
3.6K calls
2.1K puts
Total value of holdings $234M
$11K calls
$6K puts
Market Cap $505M
108,831,000 Shares Out.
Institutional ownership 64.82%
# of Institutions 77

Quarterly Institutional Activity in ADGI

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding ADGI

View all
View all

Latest Institutional Activity in ADGI

Top Purchases

Q1 2025
Sg Americas Securities, LLC Shares Held: 78.8K ($261K)
29.6K Shares purchased
60.26% Added
Q4 2024
Mithril Ii Gp LP Shares Held: 11.2M ($37.2M)
11.2M Shares purchased
New Holding
Q4 2024
Gsa Capital Partners LLP Shares Held: 462K ($1.53M)
462K Shares purchased
New Holding
Q4 2024
Ubs Group Ag Shares Held: 387K ($1.28M)
335K Shares purchased
637.82% Added
Q4 2024
Two Sigma Advisers, LP Shares Held: 304K ($1.01M)
282K Shares purchased
1276.47% Added
View All Buyers

Top Sells

Q1 2025
Rhumbline Advisers Shares Held: 79.1K ($262K)
16.6K Shares sold
17.37% Reduced
Q4 2024
Orbimed Advisors LLC Shares Held: 1.15M ($3.8M)
579K Shares sold
33.5% Reduced
Q4 2024
Citadel Advisors LLC Shares Held: 65.5K ($217K)
559K Shares sold
89.51% Reduced
Q4 2024
Millennium Management LLC Shares Held: 37.9K ($125K)
327K Shares sold
89.62% Reduced
Q4 2024
Deep Track Capital, LP Shares Held: 10.7M ($35.4M)
264K Shares sold
2.41% Reduced
View All Sellers

About ADGI

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

ADGI Chart by TradingView
ADGI Fundamental Data by TradingView

Insider Transactions at ADGI

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
Dec 31 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
103,474 -3.26%
$0 $0.45 P/Share
Dec 30 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
86,545 -2.66%
$0 $0.48 P/Share
Dec 27 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
83,744 -2.51%
$0 $0.52 P/Share
Dec 26 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
83,817 -2.45%
$0 $0.54 P/Share
Dec 24 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
68,161 -1.95%
$0 $0.51 P/Share
Dec 23 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
75,776 -2.12%
$0 $0.45 P/Share
Dec 20 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
119,805 -3.25%
$0 $0.42 P/Share
Dec 19 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
152,067 -3.96%
$0 $0.43 P/Share
Dec 18 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
74,764 -1.91%
$0 $0.47 P/Share
Dec 17 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
97,410 -2.43%
$0 $0.48 P/Share
Dec 12 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
125,000 -2.97%
$0 $0.58 P/Share
Dec 11 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
160,400 -3.68%
$0 $0.59 P/Share
Dec 10 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
175,000 -3.86%
$0 $0.59 P/Share
Dec 09 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
150,000 -3.2%
$0 $0.61 P/Share
May 29 2024
Terrance Mcguire
SELL
Open market or private sale
Indirect
112,381 -2.34%
$112,381 $1.66 P/Share
Jan 19 2024
Adimab, LLC
SELL
Open market or private sale
Direct
5,000,000 -18.74%
$15,000,000 $3.95 P/Share
Sep 01 2022
David Hering Chief Executive Officer
BUY
Open market or private purchase
Direct
8,000 +50.0%
$32,000 $4.52 P/Share
Aug 19 2022
Marc Elia
BUY
Open market or private purchase
Indirect
584,451 +5.94%
$2,337,804 $4.62 P/Share
Aug 18 2022
Marc Elia
BUY
Open market or private purchase
Indirect
1,265,549 +12.75%
$5,062,196 $4.31 P/Share
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
1.73M Shares
From 1 Insiders
Open market or private sale 1.73M shares

Track Institutional and Insider Activities on ADGI

Follow Adagio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADGI shares.

Notify only if
Any

Insider Trading

Get notified when an Adagio Therapeutics, Inc. insider buys or sells ADGI shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Adagio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADGI